New NS5B polymerase inhibitors for hepatitis C

Author： Legrand-Abravanel Florence Nicot Florence Izopet Jacques

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.8, 2010-08, pp. : 963-975

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis C therapy with HCV NS5B polymerase inhibitors

By Soriano Vincent Vispo Eugenia de Mendoza Carmen Labarga Pablo Fernandez-Montero Jose Vicente Poveda Eva Treviño Ana Barreiro Pablo

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1161-1170

Informa Healthcare

Access to resources Recommend Favorite

Allosteric Inhibitors of Hepatitis C NS5B RNA-dependent RNA Polymerase°

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 99-110

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside Inhibitors of Hepatitis C Virus NS5B Polymerase: A Systematic Review

Current Drug Targets, Vol. 17, Iss. 13, 2016-09 ,pp. : 1560-1576

Bentham Science Publishers

Access to resources Recommend Favorite

NS5B RNA Dependent RNA Polymerase Inhibitors: The Promising Approach to Treat Hepatitis C Virus Infections

Current Medicinal Chemistry, Vol. 17, Iss. 32, 2010-11 ,pp. : 3806-3826

Bentham Science Publishers

Access to resources Recommend Favorite

Design and Synthesis of Amino Acid Tethered Thiazolones to Screen for Hepatitis C NS5B Polymerase Inhibitors

Letters in Drug Design & Discovery, Vol. 14, Iss. 12, 2017-10 ,pp. : 1376-1381

Bentham Science Publishers

Access to resources Recommend Favorite